News

Sant Pau publishes to Circulation Research

The Dra. Gemma Arderiu, from the Research Group on Molecular and therapeutic pathology of atherothrombotic and ischemic diseases of the Research Institute of Sant Pau, is the first signer of the artic...

The circulating microRNA, key biomarkers for the diagnosis of patients with stable coronary heart disease

Having specific biomarkers that help improve decision-making and develop new therapeutic strategies in case of coronary heart disease is key, and in this line researchers from the CIBER of Cardiovascu...

The different clinical profiles of Huntington’s disease are associated with two specific neural signatures

Researchers from the group Brain Cognition and Plasticity of the Biomedical Research Institute of Bellvitge (IDIBELL) and the Institute of Neurosciences of the University of Barcelona (UB), with the c...

A group of citizens visit the La Marató project at the Research Institute of Sant Pau

Dr. Josep Julve, from the research group Cardiovascular Risk Metabolic Bases, from the Research Institute of Sant Pau, explained the project funded by La Marató de TV3 in which he is working on a gro...

Sant Pau develops a drug that destroys metastatic cells with cancer without harming the healthy ones

The Oncogenesis and Antitumor Research Group, from the Research Institute of the Hospital de Sant Pau-IIB Sant Pau, led by Dr. Ramon Mangues, has developed the first nanometric-sized drug that is sele...